Higher basal adiponectin levels are associated with better ovarian response to gonadotropin stimulation during in vitro fertilization

Gynecologic and Obstetric Investigation

Volumn 60, Issue 3, 2005, Pages 167-170

  Liu, Yung Hsien ^a   Tsai, Eing Mei ^b   Wu, Lee Chen ^b   Chen, Su Yin ^b   Chang, Ya Hwei ^a   Jong, Shiang Bin ^b   Chan, Te Fu ^b  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adiponectin; In vitro fertilization; Ovarian stimulation

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GONADOTROPIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONCEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; OOCYTES; OVARY;

EID: 26444574328     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086633     Document Type: Article

References (21)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
3. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-2741.
4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
5. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
7. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819.
8. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
9. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
10. Norman RJ, Clark AM: Obesity and reproductive disorders: A review. Reprod Fertil Dev 1998;10:55-63.
11. Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, et al: Fat and female fecundity: Prospective study of effect of body fat distribution on conception rates. BMJ 1993;306:484-487.
12. Wass P, Waldenstrom U, Rossner S, Hellberg D: An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod 1997;12:2057-2060.
13. Glueck CJ, Streicher P, Wang P: Treatment of polycystic ovary syndrome with insulin-lowering agents. Expert Opin Pharmacother 2002;3:1177-1189.
14. Seli E, Duleba AJ: Optimizing ovulation induction in women with polycystic ovary syndrome. Curr Opin Obstet Gynecol 2002;14:245-254.
15. Berg AH, Combs TP, Scherer PE: ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89.
16. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133.
17. Galtier-Dereure F, Pujol P, Dewailly D, Bringer J: Choice of stimulation in polycystic ovarian syndrome: The influence of obesity. Hum Reprod 1997;12(suppl 1):88-96.
18. Cano F, Garcia-Velasco JA, Millet A, Remohi J, Simon C, Pellicer A: Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women. J Assist Reprod Genet 1997;14:254-261.
19. Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T: Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000;79:43-48.
20. Lundin K, Bergh C, Hardarson T: Early embryo cleavage is a strong indicator of embryo quality in human IVF. Hum Reprod 2001;16:2652-2657.
21. Huber-Buchholz MM, Carey DG, Norman RJ: Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999;84:1470-1474.